| Emitents | Olainfarm, AS (213800WCG52W62ENOP27) |
| Veids | Finanšu pārskati |
| Valoda | EN |
| Statuss | Publicēts |
| Versija | |
| Datums | 2010-02-26 16:07:47 |
| Versijas komentārs | |
| Teksts |
Olaine, February 26, 2010
“Olainfarm” makes the record profit of 2.5
million lats in 2009
Consolidated profit and loss statement of AS „Olainfarm”
for 2009 shows that the company has made the net profit of 2.56
million lats (3.64 million euros). In fourth
quarter alone Olainfarm has made nearly 1.3 million lats (more than
1.8 million euros). Improvement in financial results reflects
the returns from strengthened marketing effort as it has lead to
better sales of higher value-added products.
Unaudited profit and loss statement of Olainfarm for
2009 shows that the sales of Concern reached 22.4 million lats (32
million euros). Net profit of the Concern during
this period was 2 560 492 lats (3 643
251euros), while in 2008 the Concern made
a loss of 1 436 905 lats (2
044 532 euros).
“Last year for Olainfarm was the most successful year so
far. It is confirmed by our record high profits, exceeding
2.5 million lats, which is nearly twice as high as our profit
target, which, when announced, was regarded as very ambitious.
Our experience of 2009 shows that if the necessary steps are
taken on a timely manner – meaning investments in promotion, new
markets, development of new products, it is possible to achieve
considerable results. We will continue working at the
development of new products, registration of new products and
exploration of new markets and entering them,” says Valerijs
Maligins, Chairman of Olainfarm’s Management Board..
During 2009 the sales grew particularly strongly in
markets where particularly strong marketing effort was
made. Sales to Russia grew by 33%, to Belarus by 10%,
Kazakhstan and Azerbaijan both grew by 65%. Ukraine has become
the second biggest market for the company as about 14% of company’s
sales were made there.
During 2009 45 new registrations in 13 different
countries have been approved. Registrations have taken place
in some countries that have so far been rather exotic for company’s
sales, including Tajikistan, Turkmenistan, Poland, Albania and
Australia. Registration processes have also been launched in
Romania and Vietnam. . Products that are being
registered include totally new names for the company, like
meldonium, olanzapine, amlodipine, flukonazole, terbinafine and
memantine. Good Manufacturing Practice certificate for
production of 2 new active substances has also been obtained in
2009. First ever shipment of final dosage forms
to Australia has taken place in 2009.
AS „Olainfarm“ is one of the largest companies in
Baltic countries with nearly 40 years of experience in production
of medicines and chemical and pharmaceutical products. The key
principle of company’s operations is to produce reliable and
effective top quality products for Latvia and the rest of the
world. Currently products of “Olainfarm” are being exported to
more than 30 countries worldwide, including the Baltics, Russia,
other CIS, Europe, North America, Asia, Australia
Information prepared by
Salvis Lapins
JSC "Olainfarm"
Deputy CFO
tel. +371 6 7013717,
cell: + 371 2 6448873
fax. + 371 6 7013777
|
| Pielikumi |